NasdaqGM:ALVOBiotechs
Alvotech (ALVO) Could Be 76% Below Fair Value On New $75 Million Debt Facility
Why Alvotech’s New Debt Facility Matters for Investors
Alvotech (NasdaqGM:ALVO) has amended its credit agreement to add a new term loan facility of up to $75 million, following a recent $165 million equity raise. This provides the company with additional financial flexibility.
Taken together, the undrawn term loan and the fresh equity funding provide Alvotech with access to $240 million in new capital. The company plans to use this to support its biosimilar pipeline, upcoming product launches...